Global Recombinant Human Insulin Industry Report 2015

20:00 EDT 20 Jul 2015 | Globe Newswire

Dublin, July 21, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( has announced the addition of the "Global Recombinant Human Insulin Industry Report 2015" report to their offering.

The Recombinant Human Insulin industry Report 2015 is a professional and in-depth study on the current state of the Recombinant Human Insulin Industry with a focus on the Chinese situation.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Human Insulin market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Recombinant Human Insulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on the Recombinant Human Insulin industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Human Insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 126 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Key Topics Covered:

Chapter One Recombinant Human Insulin Industry Overview

Chapter Two Recombinant Human Insulin International and China Market Analysis

Chapter Three Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis

Chapter Four Recombinant Human Insulin Major Countries Import Export Consumption

Chapter Five Recombinant Human Insulin Manufacturing Process and Cost Structure

Chapter Six 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast

Chapter Seven Recombinant Human Insulin Key Manufacturers Analysis

Chapter Eight Up and Down Stream Industry Analysis

Chapter Nine Recombinant Human Insulin Marketing Channels Analysis

Chapter Ten Recombinant Human Insulin Industry Development Trend

Chapter Eleven Recombinant Human Insulin Industry Development Proposals

Chapter Twelve Recombinant Human Insulin New Project Investment Feasibility Analysis

Chapter Thirteen Global and China Recombinant Human Insulin Industry Research Conclusions

Companies Mentioned:

  • Bioton
  • Dongbao
  • Eli Lilly
  • Novo Nordisk
  • United Laboratories (TUL)

For more information visit

CONTACT: Research and Markets
         Laura Wood, Senior Manager

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Pharmaceuticals

Primary Logo


More From BioPortfolio on "Global Recombinant Human Insulin Industry Report 2015"

Quick Search